When your doctor prescribes Kogenate FS, the medication from Bayer Pharmaceuticals to treat hemophilia A (classic hemophilia), you can receive a trial supply of 6 free samples with the help of the website MyRxCoupons.com
To take advantage of this free offer, click here: Kogenate FS offer.
About Kogenate FS and hemophilia A
(taken in part from the official Kogenate FS website)
Kogenate® FS, antihemophilic factor (recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.
* Real joint protection when used as routine prophylaxis in children (0-16years) with no preexisting joint damage.
* 92.7% of bleeding episodes in PTPs managed with 1 to 2 infusions.
* 88.1% of bleeding episodes in PUPs and MTPs managed with 1 to 2 infusions.
Hemophilia is a genetic disorder that impair the body’s ability to control blood clotting (or coagulation) which is used to stop bleeding when a blood vessel is broken. Hemophilia A is the most common form of the disorder, present in about 1 in 5,000–10,000 male births. Hemophilia is more likely to occur in males than females. When a blood vessel is injured, a temporary scab does form, but the missing coagulation factors prevent fibrin formation, which is necessary to maintain the blood clot. A hemophiliac does not bleed more intensely than a person without it, but can bleed for a much longer time. Even a minor injury can result in blood loss lasting days or weeks, or even never healing completely. If this occurs in an area such as the brain or inside joints, this can be fatal or permanently debilitating.
Additional Kogenate FS resources
LINK video exercise guide for hemophilia patients – See it now
LINK video insurance guide for hemophilia paients – See it now